Filing Details

Accession Number:
0000905718-20-001130
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-23 11:12:44
Reporting Period:
2020-11-19
Accepted Time:
2020-11-23 11:12:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566373 F-Star Therapeutics Inc. SBPH Pharmaceutical Preparations (2834) 522386345
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1808248 Lori Firmani C/O Spring Bank Pharmaceutcals, Inc.
35 Parkwood Drive, Suite 210
Hopkinton MA 01748
Vp Of Finance And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-19 3,750 $0.00 5,542 No 4 M Direct
Common Stock Acquisiton 2020-11-19 12,500 $0.00 18,042 No 4 A Direct
Common Stock Disposition 2020-11-20 175 $4.76 17,867 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2020-11-19 3,750 $0.00 3,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
  2. All unvested issued and outstanding RSUs accelerated and vested in full in connection with the closing of the business combination with F-star Therapeutics Limited.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.64 to $4.88 per share. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.